Charles River Laboratories Intl. Inc vs Essex Property Trust, Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: Essex Property Trust, Inc. is the larger of the two by market cap, and Essex Property Trust, Inc. pays a 3.93% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | ESS | |
|---|---|---|
Market Cap | $13.46B | $18.15B |
Sector | Health | Real Estate |
52-Week High | $282.00 | $298.33 |
52-Week Low | $145.57 | $239.61 |
Enterprise Value | $16.30B | $24.75B |
Dividend Yield | — | 3.93% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →